Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Urgent Need for Consensus on Systemic Treatments for Atopic Dermatitis in Childbearing-Age Populations
Experts on atopic dermatitis weigh the risks and rewards of systemic treatments for pregnant patients and provide clinical insights on monitoring for adverse effects associated with dupilumab.
EP: 1.Unveiling Treatment Gaps: Expert Perspectives on the Undermanagement of Patients with Atopic Dermatitis and Childbearing Potential
EP: 2.Fostering Communication: Promoting Dialogue on Atopic Dermatitis Treatment Concerns in Patients of Childbearing Potential
EP: 3.Exploring Changes in Atopic Dermatitis Severity Across the Pregnancy Journey
EP: 4.Navigating Treatment Choices: Balancing Treatment Options for Childbearing-Age Patients
EP: 5.Insights on Transcription Binding in Atopic Dermatitis
EP: 6.Informed Decisions: Dialogue with Treatment-Naïve Pregnant Patients Regarding Systemic Atopic Dermatitis Treatment Options
EP: 7.Managing Atopic Dermatitis Treatment Escalation in Pregnancy: Considerations and Approaches
Now Viewing
EP: 8.Urgent Need for Consensus on Systemic Treatments for Atopic Dermatitis in Childbearing-Age Populations
EP: 9.Considerations for Breastfeeding, Lactation, and Postpartum in Family Planning Patients with Atopic Dermatitis
EP: 10.Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing Potential
EP: 11.Ten Clinical Considerations to Manage AD in Pregnant Patients
Recent Videos
Related Content
